Life Sciences

Lantheus Logo

Lantheus Announces AI Product Approval

Lantheus announces the first and only FDA cleared AI-Enabled PSMA Digital Application.

Lantheus Holdings, Inc. announced that its subsidiary, EXINI Diagnostics AB, was granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its digital application, aPROMISE (automated PROstate Cancer Molecular Imaging Standardized Evaluation). Read the full article here.

BARDA Mask Innovation Challenge

Win $500,000 to Design a Better Mask

The Biomedical Advanced Research & Development Authority (BARDA) has launched a Mask Innovation Challenge focused on improving the comfort, utility, and protective factor of available masks that are used by the general population.

BARDAis offering up to $500,000 for new & improved mask designs that are low-cost & mass-producible. Apply now — the challenge application closes on April 21stat 5:00 PM ET!

For more information and to apply visit: https://www.challenge.gov/challenge/mask-innovation-challenge/

MassBio BioReady Community

Chelmsford is BioReady

Chelmsford is now a Platinum-rated community for biotech

Chelmsford, Massachusetts—The Town of Chelmsford has achieved the highest rating possible of Platinum status to announce their support to hosting and expanding the bio-tech industries in their community. This was achieved by modernized zoning bylaws with overlay districts, expedited permitting process, public and accessible infrastructure to include currently established biotechnology businesses. 

“Chelmsford efforts to position themselves as a Platinum-rated BioReady community serves as a testament to the town’s ability to support the life sciences industry and foster its continued growth,” said Ben Bradford, Vice President of Economic Development and Membership, MassBio. “This area, located just 35 minutes from the state’s biotechnology hubs, boasts incredible access to higher education, a skilled workforce, public transportation, and much more. We are excited to see the progress Chelmsford makes as the next biotech mini-cluster.” ~ Ben Bradford, Vice President of Economic Development, MA Biotechnology Council.

“The Town of Chelmsford is the base location to many advanced technologies and progressive scientific companies, such as; Zoll Medical, Brooks Automation, TeleFlex, 3M to name a few. Our partnerships with UMass Lowell, Middlesex Community College and the vocational schools provide an excellent system for skilled growth and collaboration. It’s time that the Chelmsford Cross Roads at Route 129 be considered as the competitive advantage that it is with more affordable real estate options, network of modern businesses and a municipal team ready to assist.” ~ Paul Cohen, Chelmsford Town Manager.

The Town of Chelmsford will join the other Platinum communities in the region of Route 3 / Route 495, alongside Bedford, Billerica, Burlington, and Lowell, all Middlesex 3 Coalition communities, which the town views as a pivotal partner for attracting businesses to the community.

The Chelmsford Business Development Office is striving to attract industry-leaders from the biotechnology world to our available spaces. Site tours, technical project reviews, Route 129 stakeholder group meetings are available; learn much more at https://chelmsfordcrossroads129.com/.

“The Route 3 / Route 495 region provides abundant resources, from the Middlesex 3 Coalition, MassEcon, MA Office of Business Development, MA Biotechnology Council, to the Greater Lowell Chamber of Commerce and more.“ ~ Lisa Marrone, Director of Business Development.

Communities are ranked on a scale of Bronze, Silver, Gold or Platinum, and the system helps Massachusetts cities and towns market themselves to biotechnology companies looking to expand or relocate. As part of the campaign, the MassBio’s Innovation Services (MBIS) enables deeper connections and pursuits. To learn more and view full ratings criteria, visit MassBio’s BioReady® Communities web page at https://www.massbio.org/initiatives/bioready-communities/.